Wuling Motors Holdings Limited: Supplemental Announcement to 2025 Annual Report – Investor Insights
Key Highlights for Investors
- Share Option Scheme Update: The Company provides new details on its Share Option Scheme, including the maximum number of options available, vesting schedules, and conditions for grant and exercise.
- Material Investments and Treasury Management: Significant information on the company’s investment in structured deposit products and equity instruments is disclosed, including the size, risk management, and return profiles.
- Internal Control Improvements & Compliance: The Group clarifies enhancements in internal control and oversight policies, especially after a recent misunderstanding in treasury management.
- Related Party and Connected Transactions: The announcement confirms compliance with Hong Kong Listing Rules and clarifies no additional reportable connected transactions occurred.
Detailed Analysis
Share Option Scheme – New Investor-Relevant Details
- Maximum Options: At the start and end of 2025, 98,944,839 shares were available for grant, representing 3% of issued shares, excluding treasury shares. Each participant may be granted options up to 1% of shares in issue within any 12-month period.
- Vesting and Exercise Schedule:
- Options vest over 3 tranches after a two-year restriction period from the grant date: 30% after year 2, 30% after year 3, and 40% after year 4, fully vesting by the fifth anniversary.
- Exercise Price: Determined as the highest of (1) grant date closing price, (2) 5-day average prior to grant, or (3) nominal value.
- Current Status: As of end 2024, all previously granted options lapsed due to unmet performance targets. Further grants are subject to approval under Guangxi SASAC’s guidelines for state-owned listed companies.
- Scheme Expiry: The scheme expires on 10 November 2027, with a remaining life of 1 year and 314 days as of 31 December 2025.
Material Securities Investment Activities
- Investment Portfolio:
- As of 31 December 2025, the Group held RMB 22.5 million in an unlisted equity instrument and RMB 540 million in structured deposit products, totaling RMB 562.5 million, or 5.4% of total assets.
- The equity investment is in Liuzhou Lingte, a related joint venture originally acquired for engine product development, now held for treasury management and not for trading.
- No dividends were received from this equity investment in 2025.
- Structured Deposit Products:
- From July 2025 to March 2026, the Group subscribed to 77 principal-guaranteed structured deposits with 9 PRC licensed banks (aggregate principal: RMB 17.75 billion). As of 31 December 2025, RMB 540 million remained outstanding, all with Hua Xia Bank (HXB) due to year-end rollover timing; all matured by July 2026.
- Returns from these structured deposits (RMB 16.99 million in 2025) were recognized as bank interest income.
- These products featured capital protection and minimum guaranteed returns, with short tenors (2 weeks to 1.5 months), and were funded with idle internal funds, not affecting working capital.
- Important Note: Subscription to these structured products has ceased since early March 2026 due to internal policy review and required staff training after a misunderstanding by treasury staff.
- Investment Policy and Risk Management:
- Permitted investments: bank deposits, principal-guaranteed structured deposits (currently suspended pending policy updates and training), and strategic equity investments related to main business lines.
- Prohibited investments: leveraged/speculative products, non-strategic unlisted equities, and products that may impair liquidity or working capital.
- Risk controls: Aggregate structured deposit investments are capped at 5% of total assets (de minimis threshold under HK Listing Rules), only principal-guaranteed low-risk items with PRC licensed banks allowed, and single investment tenors not exceeding 6 months unless Board approved.
- Counterparty selection: Only PRC-licensed banks or reputable, regulated financial institutions are eligible. Counterparty concentration is managed by diversifying across banks, though year-end rollover resulted in all structured deposits with HXB as of 2025 year-end.
- Liquidity management: Cash flow is monitored to ensure investment maturities align with operational needs; no funds required for operations are invested.
Connected and Related Party Transactions
- The Group confirmed that, apart from transactions already disclosed in the 2025 Annual Report (Acquisition of Right-of-Use Assets, Energy Framework, Consignment and Purchase Frameworks, etc.), there were no other related party transactions that triggered additional reporting requirements under Chapter 14A of the Listing Rules.
- All required disclosures and compliance measures have been met.
Governance and Oversight
- Investment decisions exceeding RMB 30 million require Board review and approval.
- The Board and Audit Committee monitor compliance, internal controls, and financial disclosure.
- Enhanced internal controls and staff training are being implemented to address the recent misunderstanding in treasury management related to structured deposits.
Potential Share Price Implications
- Ceasing Structured Deposit Subscriptions: The halt of subscriptions to structured deposit products following internal control concerns and the review of treasury policies could be seen as a positive move to tighten risk management and compliance. However, it also means the company may not enjoy the above-market returns previously generated by these products, which could impact future earnings.
- All Share Options Lapsed: The lapse of all previously granted share options due to unmet performance targets may be viewed as a governance positive, signaling alignment with performance, but also means no immediate dilution risk or management incentive from the scheme until further grants are approved.
- Compliance and Transparency: The Group’s proactive disclosure and commitment to enhanced internal controls may bolster investor confidence, but details around the internal misunderstanding could raise concerns about past risk oversight.
What Should Shareholders Watch?
- Watch for Future Share Option Grants: Any new grants under the Share Option Scheme will require compliance with SASAC guidelines and could affect management incentives and share dilution.
- Monitor Investment Policy Changes: Investors should pay attention to any resumption or changes in the Group’s treasury management and structured deposit investments once internal controls and training have been completed.
- Review Earnings Impact: The cessation of structured deposit investments could impact interest income in future periods.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full company disclosures and consult their own advisors before making investment decisions. The author and publisher accept no liability for actions taken based on this article.
【廣東話版本】
五菱汽車控股有限公司二零二五年年報補充公告——投資者重點資訊
重點摘要
- 期權計劃最新情況：公司補充了更多有關股份期權計劃細節，包括可授出最大期權數目、歸屬安排及行使條件。
- 重大投資及資金管理：公司披露大量有關結構性存款產品及權益工具的投資詳情，包括規模、風險管理及回報。
- 內部監控及合規：集團釐清因財務管理誤會後，已提升內控及監察措施。
- 關連交易及持續關連交易：公司確認已遵守港交所上市規則，並無其他需另行披露的關連交易。
詳細內容
股份期權計劃—投資者需知
- 最大可授期權：於2025年初及年末均有98,944,839股可供授出，佔已發行股本3%（不包括庫藏股），每位參與者12個月內最高可獲1%股份。
- 歸屬及行使安排：期權於授出日起24個月限制期後分三期歸屬：第2年後30%、第3年後再30%、第4年後餘下40%，第5年完全歸屬。
- 行使價：按董事會決定，取三者最高值：授出日收市價、前五日平均價、股份面值。
- 當前狀況：截至2024年底，全部期權因未達標準已失效，未來授出需經廣西國資委指引審批。
- 計劃有效期：2027年11月10日屆滿，至2025年12月31日尚餘1年314日。
重大證券投資活動
- 投資組合：
- 截至2025年12月31日，集團持有一項未上市權益工具（RMB2,250萬）及結構性存款產品（RMB5.4億元），合共RMB5.625億元，佔總資產5.4%。
- 權益投資為與柳州菱特合資開發發動機產品，現為財務管理持有，非交易性質，2025年未收息。
- 結構性存款產品：
- 2025年7月至2026年3月，集團向九間內地持牌銀行申購77個本金保證結構性存款，總本金RMB177.5億元，2025年底未到期餘額為RMB5.4億元，全部為華夏銀行產品，2026年初全部到期。
- 2025年相關利息收入RMB1,699.2萬元。
- 產品本金保證，短期（2星期至1.5個月），資金均為內部閒置，不影響營運資金。
- 重要：自2026年3月起，因財務誤會，公司已暫停投資結構性存款，並需待內控及培訓完成後再作決定。
- 投資政策及風險管理：
- 允許：銀行存款、本金保證結構性存款（暫停中）、與主營業務具協同的策略性權益投資。
- 禁止：槓桿/投機性產品、非策略性未上市權益、損害流動資金的投資。
- 風險管控：結構性存款總額受控於資產5%以下、只選擇內地持牌銀行本金保證產品、單一產品期限不超6個月（特殊情況需董事會批核）。
- 對手方選擇：只選擇受監管持牌銀行，並分散存款防止集中風險。
- 流動性管理：確保產品到期與營運資金需求相符，不投資於即時所需資金。
關連及持續關連交易
- 除已於2025年年報披露之交易外，無其他觸發額外披露需要的關連交易。
- 全部合規，無違規情況。
管治及監察
- 超過RMB3,000萬投資需董事會審批。
- 董事會及審核委員會定期監控合規及內控。
- 因財務誤會，現正加強內控及員工培訓。
對股價潛在影響
- 暫停申購結構性存款：短期或正面（強化內控），但未來或減少財務收入。
- 期權全部失效：短線無稀釋壓力或管理激勵，未來授出需審批。
- 合規及透明：主動披露及強化管理，有助提升投資者信心，但財務誤會亦反映過去監控需改善。
股東需密切留意
- 未來期權授出：一旦再授出，需符國資委要求，或影響管理激勵及股份稀釋。
- 投資政策變化：內控及培訓完成後會否重啟結構性存款投資。
- 財務收入：結構性存款暫停後，利息收入或受壓。
免責聲明：本文僅供資訊參考，非任何投資建議。投資者應審閱公司全部公告及諮詢專業顧問。作者及出版方不就本文所引致的任何投資行為負責。
